Indeed, FcRn mediated tumor protection through DC activation of endogenous tumor-reactive CD8+-T cells via the cross-presentation of IgG complexed antigens, in a colorectal cancer model, using fcgrt knock-out mice [18]. The gene discussed is FCGRT; the disease is colorectal cancer.